Share on facebook Share on Twitter Share on Google Plus Share This

Brain Tumor

Doctors + Care Team

Carl B. Heilman, MD

Carl B. Heilman, MD

Accepting New Patients

Title(s): Neurosurgeon-in-Chief; Chairman of Neurosurgery; Professor, Tufts University School of Medicine
Department(s): Neurosurgery
Appt. Phone: 617-636-5860
Fax #: 617-636-7587

Meningiomas, acoustic neuromas, skull base surgery, pituitary surgery, Chiari surgery

View Full Profile

Julian K. Wu, MD

Julian K. Wu, MD

Accepting New Patients

Title(s): Associate Chairman, Neurosurgery; Chief, Neurosurgical Oncology; Neurosurgery Residency Program Director; Professor, Tufts University School of Medicine
Department(s): Neurosurgery
Appt. Phone: 617-636-4500
Fax #: 617-636-7587

Neuro-oncology, Gamma Knife radiosurgery, meningiomas, pituitary tumors, gliomas, brain metastasis, trigeminal neuralgia

View Full Profile

Tomo Tarui, MD

Tomo Tarui, MD

Accepting New Patients

Title(s): Director, Baby Neurology Program; Pediatric Neurologist; Assistant Professor, Tufts University School of Medicine
Department(s): Pediatrics, Pediatric Neurology
Appt. Phone: 617-636-8100
Fax #: 617-636-8375

Pediatric neurology, fetal neurology, neonatal neurology, neurological intensive care

View Full Profile

Research + Clinical Trials


A Phase II Trial of Nifurtimox for Refractory or Relapsed Neuroblastoma or Medulloblastoma

This study is being done to test the effect of a drug, nifurtimox, against neuroblastoma and medulloblastoma in children. Nifurtimox is a drug that has been used in South America for many years to treat a parasitic disease known as Chagas Disease. It is not approved by the Food and Drug Administration for routine use in neuroblastoma or medulloblastoma in the United States, but the FDA is allowing it to be used in research studies like this one. Limited early observations, suggest that nifurtimox may have anti-tumor activity for neuroblastoma and medulloblastoma. We do not know whether nifurtimox will shrink/kill tumor cells effectively in children. Therefore, the major goal of the study is to learn if nifurtimox in combination with other common chemotherapy drugs is effective in shrinking/killing neuroblastoma and medulloblastoma cells. We will also be collecting information about any side effects that the drug may have.
More information about research and clinical trials

Tufts Medical Center and Floating Hospital for Children have high quality care.

Quality + Safety

A world-class pediatric teaching hospital shouldn’t make you and your child feel small.  At Floating Hospital for Children our littlest patients are our biggest priority. This means we’re committed to providing the highest quality of care in a safe, friendly environment.

Learn more
A child in the pediatric emergency department at Floating Hospital for Children.

Floating Ranks With the Best

The Leapfrog Group gave Floating Hospital for Children and Tufts Medical Center an “A” rating for outstanding patient safety in 2014.

Learn more
Floating Hospital for Children has a strong history of innovation.

A Fresh Breath of Air

Floating Hospital for Children began its life as a hospital ship in the Boston Harbor in 1894 before coming onshore permanently in 1931.

Learn more